Oncology & Cancer

Actinic keratosis diagnosis ups cumulative risk for skin cancer

(HealthDay)—The annual increase in risk for cutaneous squamous cell carcinoma (cSCC) is higher for patients who have received a diagnosis of one or more actinic keratoses (AKs), according to a study published online March ...

Oncology & Cancer

Pulse photodynamic therapy for AK cuts side effects

(HealthDay)—Pulse photodynamic therapy (pulse-PDT) and corticosteroid pulse-PDT reduce treatment-induced erythema in patients treated for actinic keratoses (AK), according to a study published online Feb. 8 in the British ...

Diseases, Conditions, Syndromes

Ablative fractionated laser Tx promising for actinic keratosis

(HealthDay)—For patients with actinic keratoses (AKs), one treatment with ablative fractionated laser (AFXL) produces a modest temporary reduction in AKs, according to a study published in the February issue of the Journal ...

Oncology & Cancer

Added benefit of ingenol mebutate is not proven

The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act ...

Diseases, Conditions, Syndromes

New laser resurfacing therapy promising for actinic keratoses

(HealthDay)—For patients with facial photodamage and actinic keratoses (AK), treatment with a new fractional resurfacing technique that uses a 1927-nm nonablative thulium laser reduces the number of facial AK and produces ...